Bupropion and amantadine in sexual function in patients with methadone

Phase 3

• Conditions: F11.281; Sexual dysfunction.; Opioid dependence with opioid-induced sexual dysfunction

• Registration Number: IRCT20170606034348N5
• Lead Sponsor: Babol University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 August 2019

Recruitment & Eligibility

• Status: Complete
• Sex: Male
• Target Recruitment: 40

Inclusion Criteria

Patients aged 20 to 70 years
Consumers of any drugs and cigarettes or herbal medicines
Methadone consumption

Exclusion Criteria

Female patients
single men
patients who are not satisfied with the study
Diseases affecting sexual function (known diabetes, cardiovascular and endocrine disorders, well-known neurological disease affecting sexual function, etc.)
Use any type of drug that has an effect on sexual function (e.g. Amphetamines based on patient's history)

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Sexual dysfunction. Timepoint: At the beginning of the study and one month after the start of the drug. Method of measurement: International Index of Erectile Function Questionnaire.